Protecting Minors in Federal Health Plans Act

Continued Coverage for Transitioning Individuals: Individuals under 18 who are already undergoing hormone therapy covered by a contract may continue that therapy under a physician-supervised reduction schedule for up to one year after the effective date of the Act. (Section 2(a)(3))

Coverage for Disorders of Sexual Development: The bill ensures that services provided to individuals with a medically verifiable disorder of sexual development, such as those with specific chromosomal or tissue characteristics, are not considered prohibited gender-saffirming care. (Section 2(a)(1)(C)(i))

Coverage for Specific Hormone Treatments: The bill allows for the coverage of prescriptions used to normalize puberty in those with precocious puberty, or to stimulate puberty in those with delayed puberty, provided the hormones are consistent with biological sex. (Section 2(a)(1)(C)(v-vi))

Coverage for Medical Emergencies and Injuries: Coverage is maintained for procedures intended to address physical disorders, injuries, or illnesses that pose an imminent risk of death or impairment, provided they are not for gender transition. (Section 2(a)(1)(C)(iv))

Loss of Coverage for Minors: Individuals younger than 18 years of age will no longer be eligible for coverage for gender-affirming care or services, which includes hormone therapy, puberty blockers, and surgical procedures aimed at gender transition. (Section 2(a)(1) and Section 2(a)(2))

Restrictions on Continued Treatment: For minors already undergoing covered hormone therapy, coverage can only continue for a maximum of one year following the effective date of the Act, and only if they follow a physician-supervised reduction schedule. (Section 2(a)(3))